Centene Corporation

CNC
Financial Analysis · Updated May 13, 2026 · Coverage 2026-Q2
Latest Q Revenue
$49.9B
Q1 2026 · +5% YoY
TTM ROIC
3.5%
FY2025 (adj.) · NOPAT (adj.) / Invested Capital · WACC ~8.5% · Moat spread +-5pp

Financial Snapshot


ticker: CNC step: 04 generated: 2026-05-12 source: quick-research

Centene Corporation (CNC) — Financial Snapshot

Income Statement Summary

Metric FY2022 FY2023 FY2024 YoY
Revenue $144.5B $154.0B $163.1B +6%
Health Benefits Ratio (HBR) ~87.7% ~87.7% ~88.5%+
Operating Margin ~2.5% ~2.8% ~2.7%
Net Income ~$1.7B ~$2.7B $3.3B +22%
EPS (GAAP diluted) $2.07 ~$5.00 ~$6.30
EPS (adjusted diluted) $5.78 ~$7.00+ ~$7.50

Note: FY2025 was highly disrupted — ACA losses and Medicaid HBR pressure caused multiple guidance withdrawals and a large Q4 2025 loss. FY2025 full-year results showed ~$1.5B+ in challenges before partial recovery in Q1 2026.

Cash Flow & Balance Sheet (FY2024)

Metric Value
Operating Cash Flow ~$2.3B
Free Cash Flow ~$1.4B
Cash & Equivalents ~$14B
Total Debt ~$18B

Note: FY2022 FCF was $5.3B and FY2023 was $7.3B — FY2024 decline reflects Medicaid acuity and ACA cost pressures impacting earnings.

Key Ratios (approximate)

  • P/E (forward): ~8–10x | P/B: ~1.2x | FCF Yield: ~5–8%
  • Revenue Growth (FY2024): +6% | Net Margin: ~2%

Growth Profile

Centene has grown revenue rapidly through Medicaid contract wins and ACA marketplace expansion, but profitability has been highly volatile. The 2023–2025 period was defined by: (1) Medicaid redeterminations removing ~1.5M low-acuity members and raising average acuity/HBR; (2) ACA Marketplace adverse selection as enhanced subsidies fueled enrollment of high-cost members; and (3) state rate increases lagging medical cost inflation. ACA membership has already contracted sharply — from 5.5M at end-2025 to ~3.5M in Q1 2026 (-36%) as subsidy expirations drove healthier enrollees out.

Forward Estimates

  • FY2026: Revenue guidance reduced due to ACA membership losses; Medicaid HBR improvement is the key earnings driver; management expects "meaningful margin improvement and renewed adjusted EPS growth" — consensus cautious, Hold rating from 20 analysts

Deeper Financial Analysis

The fundamental tier adds 9 additional research dimensions for $CNC.

Revenue Breakdown
Segment revenue, geographic mix, product-line contribution margins, and cohort dynamics.
Financial Trends
Quarter-over-quarter momentum, leading indicators, and inflection point analysis.
Balance Sheet
Debt structure, liquidity runway, dilution risk, and working capital dynamics.
Capital Allocation
Buyback cadence, M&A appetite, dividend policy, and reinvestment priorities.
Returns on Capital (ROIC)
Multi-year ROIC vs. WACC, marginal returns on reinvestment, sales-to-invested-capital efficiency, and moat spread.
GET /api/v1/research/CNC/fundamental$1.00 · Bearer token required
Markdown: /stocks/cnc/financials/md · → thesis · → memo